BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease Life Science Investing
ME Therapeutics to Pitch at CSE Capital Tech Connect During Web Summit Vancouver Life Science Investing
Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® Cream in Adults with Moderate Atopic Dermatitis Life Science Investing
Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates Life Science Investing
ARS Pharmaceuticals Announces Conference Call and Webcast for its First Quarter 2026 Financial Results Life Science Investing
ALX Oncology's Evorpacept in Combination with Zanidatamab Generates Promising, Durable Response in Patients with Advanced HER2-Positive Breast Cancer and High CD47 Expression Life Science Investing
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results Life Science Investing
NRx Pharmaceuticals Announces FDA Clearance to Proceed with Clinical Trial of NRX-101 in Combination with Robotic-enabled Transcranial Magnetic Stimulation in Patients with Depression and Suicidality Life Science Investing
Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2026 and Provides Update on Recent Business Progress Life Science Investing
Palvella Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update Life Science Investing
